secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cullinan Therapeutics, Inc. (CGEM)
CIK:        0001789972
Form:       8-K
Filed at:   2021-12-29T23:59:59+00:00
Accession:  0001193125-21-368422
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Morana Jovan-Embiricos resigns from Cullinan Oncology board effective Dec 31, 2021
--------------------------------------------------------------------------------

- Resignation to dedicate more time to role as Managing Partner of F2 Ventures Ltd. and its portfolio companies.
- Decision not due to any disagreement with the Company on operations, policies, or practices.
- Resignation effective December 31, 2021; no replacement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789972/000119312521368422/0001193125-21-368422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789972/000119312521368422/d282038d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-368422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer